Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

1.

Metabolites associate with kidney function decline and incident chronic kidney disease in the general population.

Goek ON, Prehn C, Sekula P, Römisch-Margl W, Döring A, Gieger C, Heier M, Koenig W, Wang-Sattler R, Illig T, Suhre K, Adamski J, Köttgen A, Meisinger C.

Nephrol Dial Transplant. 2013 Aug;28(8):2131-8. doi: 10.1093/ndt/gft217. Epub 2013 Jun 5.

PMID:
23739151
2.

Serum metabolite concentrations and decreased GFR in the general population.

Goek ON, Döring A, Gieger C, Heier M, Koenig W, Prehn C, Römisch-Margl W, Wang-Sattler R, Illig T, Suhre K, Sekula P, Zhai G, Adamski J, Köttgen A, Meisinger C.

Am J Kidney Dis. 2012 Aug;60(2):197-206. doi: 10.1053/j.ajkd.2012.01.014. Epub 2012 Mar 30.

PMID:
22464876
3.

Serum metabolomic profiling and incident CKD among African Americans.

Yu B, Zheng Y, Nettleton JA, Alexander D, Coresh J, Boerwinkle E.

Clin J Am Soc Nephrol. 2014 Aug 7;9(8):1410-7. doi: 10.2215/CJN.11971113. Epub 2014 Jul 10.

4.

Association of apolipoprotein A1 and B with kidney function and chronic kidney disease in two multiethnic population samples.

Goek ON, Köttgen A, Hoogeveen RC, Ballantyne CM, Coresh J, Astor BC.

Nephrol Dial Transplant. 2012 Jul;27(7):2839-47. doi: 10.1093/ndt/gfr795. Epub 2012 Jan 28.

5.

Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease.

Shlipak MG, Katz R, Sarnak MJ, Fried LF, Newman AB, Stehman-Breen C, Seliger SL, Kestenbaum B, Psaty B, Tracy RP, Siscovick DS.

Ann Intern Med. 2006 Aug 15;145(4):237-46.

PMID:
16908914
6.

Association of arterial rigidity with incident kidney disease and kidney function decline: the Health ABC study.

Madero M, Peralta C, Katz R, Canada R, Fried L, Najjar S, Shlipak M, Simonsick E, Lakatta E, Patel K, Rifkin D, Hawkins M, Newman A, Sarnak M; Health ABC Study.

Clin J Am Soc Nephrol. 2013 Mar;8(3):424-33. doi: 10.2215/CJN.07900812. Epub 2012 Dec 27.

7.

A Metabolome-Wide Association Study of Kidney Function and Disease in the General Population.

Sekula P, Goek ON, Quaye L, Barrios C, Levey AS, Römisch-Margl W, Menni C, Yet I, Gieger C, Inker LA, Adamski J, Gronwald W, Illig T, Dettmer K, Krumsiek J, Oefner PJ, Valdes AM, Meisinger C, Coresh J, Spector TD, Mohney RP, Suhre K, Kastenmüller G, Köttgen A.

J Am Soc Nephrol. 2016 Apr;27(4):1175-88. doi: 10.1681/ASN.2014111099. Epub 2015 Oct 8.

8.

Serum uric acid and chronic kidney disease: the role of hypertension.

Sedaghat S, Hoorn EJ, van Rooij FJ, Hofman A, Franco OH, Witteman JC, Dehghan A.

PLoS One. 2013 Nov 12;8(11):e76827. doi: 10.1371/journal.pone.0076827. eCollection 2013.

9.

Short-term change in kidney function and risk of end-stage renal disease.

Turin TC, Coresh J, Tonelli M, Stevens PE, de Jong PE, Farmer CK, Matsushita K, Hemmelgarn BR.

Nephrol Dial Transplant. 2012 Oct;27(10):3835-43. doi: 10.1093/ndt/gfs263. Epub 2012 Jul 3.

PMID:
22764191
10.

Association of uric acid and left ventricular mass index with renal outcomes in chronic kidney disease.

Chen SC, Chang JM, Yeh SM, Su HM, Chen HC.

Am J Hypertens. 2013 Feb;26(2):243-9. doi: 10.1093/ajh/hps020. Epub 2012 Dec 28.

PMID:
23382409
11.

Serum uric acid levels and incident chronic kidney disease in patients with type 2 diabetes and preserved kidney function.

Zoppini G, Targher G, Chonchol M, Ortalda V, Abaterusso C, Pichiri I, Negri C, Bonora E.

Diabetes Care. 2012 Jan;35(1):99-104. doi: 10.2337/dc11-1346. Epub 2011 Oct 25.

12.

Chronic kidney disease, cognitive decline, and incident dementia: the 3C Study.

Helmer C, Stengel B, Metzger M, Froissart M, Massy ZA, Tzourio C, Berr C, Dartigues JF.

Neurology. 2011 Dec 6;77(23):2043-51. doi: 10.1212/WNL.0b013e31823b4765. Epub 2011 Nov 23.

PMID:
22116945
13.

Impact of metabolic syndrome on the incidence of chronic kidney disease: a Chinese cohort study.

Yang T, Chu CH, Hsu CH, Hsieh PC, Chung TC, Bai CH, You SL, Hwang LC, Lin CM, Sun CA.

Nephrology (Carlton). 2012 Aug;17(6):532-8. doi: 10.1111/j.1440-1797.2012.01607.x.

PMID:
22487238
14.

Hypomagnesemia and the risk of death and GFR decline in chronic kidney disease.

Van Laecke S, Nagler EV, Verbeke F, Van Biesen W, Vanholder R.

Am J Med. 2013 Sep;126(9):825-31. doi: 10.1016/j.amjmed.2013.02.036. Epub 2013 Jul 24.

PMID:
23891286
15.

Development and validation of a general population renal risk score.

Halbesma N, Jansen DF, Heymans MW, Stolk RP, de Jong PE, Gansevoort RT; PREVEND Study Group.

Clin J Am Soc Nephrol. 2011 Jul;6(7):1731-8. doi: 10.2215/CJN.08590910.

16.

Uric acid and incident chronic kidney disease in a large health check-up population in Taiwan.

Wang S, Shu Z, Tao Q, Yu C, Zhan S, Li L.

Nephrology (Carlton). 2011 Nov;16(8):767-76. doi: 10.1111/j.1440-1797.2011.01513.x.

PMID:
21854506
17.

Comparison of predictability of future cardiovascular events between chronic kidney disease (CKD) stage based on CKD epidemiology collaboration equation and that based on modification of diet in renal disease equation in the Japanese general population--Iwate KENCO Study.

Ohsawa M, Tanno K, Itai K, Turin TC, Okamura T, Ogawa A, Ogasawara K, Fujioka T, Onoda T, Yoshida Y, Omama S, Ishibashi Y, Nakamura M, Makita S, Tanaka F, Kuribayashi T, Koyama T, Sakata K, Okayama A.

Circ J. 2013;77(5):1315-25. Epub 2013 Feb 21.

18.

Slower decline of glomerular filtration rate in the Japanese general population: a longitudinal 10-year follow-up study.

Imai E, Horio M, Yamagata K, Iseki K, Hara S, Ura N, Kiyohara Y, Makino H, Hishida A, Matsuo S.

Hypertens Res. 2008 Mar;31(3):433-41. doi: 10.1291/hypres.31.433.

PMID:
18497462
19.

Incident atrial fibrillation and risk of end-stage renal disease in adults with chronic kidney disease.

Bansal N, Fan D, Hsu CY, Ordonez JD, Marcus GM, Go AS.

Circulation. 2013 Feb 5;127(5):569-74. doi: 10.1161/CIRCULATIONAHA.112.123992. Epub 2012 Dec 28.

20.

Renal arterial resistive index is associated with severe histological changes and poor renal outcome during chronic kidney disease.

Bigé N, Lévy PP, Callard P, Faintuch JM, Chigot V, Jousselin V, Ronco P, Boffa JJ.

BMC Nephrol. 2012 Oct 25;13:139. doi: 10.1186/1471-2369-13-139.

Supplemental Content

Support Center